China Shineway Pharmaceutical Group Limited

2877.HK·HKSE·Healthcare
Compare
7.285+0.065 (+0.90%)today
As of Oct 23, 3:25 PM HKT · May be delayed up to 15 min · HKD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close7.220
Open7.225
Day range7.1857.370
52-week range7.12010.470
Off day high−1.15%
Off 52-week high−30.42%
Volume509.00K
Avg. volume (3M)1.46M
Market cap5.50B
EPS (TTM)1.17
Forward P/E5.77
P/E ratio (TTM)6.23
Dividend yield19.67% (1.42)
Beta (5Y)0.68
Shares outstanding755.40M
Short interest—
Earnings dateAug 27, 2025 (est.)
Analyst target8.570
Profit margin30.20%

Against its peers

Compare in full ›
2877.HK 0719.HK 603858.SS 2M7C.F 002603.SZ 000999.SZ
Market cap 5.50B 3.74B 15.61B 2.70B 26.15B 41.24B
P/E (TTM) 6.2 15.3 64.3 13.9 19.3 12.8
Forward P/E 5.8 17.3 — — 14.4 10.8
Price/book 0.6 0.6 1.5 1.1 2.4 1.8
Dividend yield 19.67% 3.25% 3.86% 3.30% 5.29% 4.02%
1-year change −14.35% −27.36% −17.38% −21.38% −12.46% −14.65%
Today +0.90% +1.13% +0.14% −0.89% +3.57% −0.88%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

What visitors to China Shineway Pharmaceutical's page also look at.

Company Mkt cap Price Today
UNITED LAB3933.HK 13.48B 6.840 −0.87%
SSY GROUP2005.HK 7.37B 2.565 −0.58%
DAWNRAYS PHARMA2348.HK 1.42B 0.940 −1.05%
BAIYUNSHAN PH0874.HK 21.02B 12.930 +1.02%
SH PHARMA2607.HK 40.79B 11.000 +1.10%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All 2877.HK news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.